MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4

Previous studies reported that miR-330-3p was involved in the progression of several cancers, but the potential roles of miR-330-3p in ovarian cancer (OC) were unclear. In the current study, we aimed to explore the expression pattern and functions of miR-330-3p in OC. The expression level of miR-330...

Full description

Bibliographic Details
Main Authors: Li Cai, Lu Ye, Xiaoqing Hu, Wenfeng He, Debao Zhuang, Qi Guo, Kuanyong Shu, Youkun Jie
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Bioengineered
Subjects:
Online Access:http://dx.doi.org/10.1080/21655979.2021.1871817
_version_ 1798034113695842304
author Li Cai
Lu Ye
Xiaoqing Hu
Wenfeng He
Debao Zhuang
Qi Guo
Kuanyong Shu
Youkun Jie
author_facet Li Cai
Lu Ye
Xiaoqing Hu
Wenfeng He
Debao Zhuang
Qi Guo
Kuanyong Shu
Youkun Jie
author_sort Li Cai
collection DOAJ
description Previous studies reported that miR-330-3p was involved in the progression of several cancers, but the potential roles of miR-330-3p in ovarian cancer (OC) were unclear. In the current study, we aimed to explore the expression pattern and functions of miR-330-3p in OC. The expression level of miR-330-3p in OC tissues and cell lines was detected using RT-qPCR. The proliferation, migration and invasion of OC cells were detected using CCK-8 assay and transwell assay, respectively. Bioinformatics analysis and luciferase reporter assay were used to analyze the targeted binding site of miR-330-3p and RIPK4. The results showed that miR-330-3p was significantly downregulated in OC tissues and cell lines. Overexpression of miR-330-3p inhibited the proliferation, migration and invasion of OC cells. Mechanistically, a dual-luciferase reported assay showed that RIPK4 is a target gene of miR-330-3p. Furthermore, rescue experiments revealed that miR-330-3p suppressed the proliferation, migration and invasion of OC cells by targeting RIPK4. In summary, our findings indicated that miR-330-3p suppressed the progression of OC by targeting RIPK4. Our results indicated that miR-330-3p/RIPK4 axis might act as a novel therapeutic target for OC treatment.
first_indexed 2024-04-11T20:39:50Z
format Article
id doaj.art-623b0522f5264bd8ba12ea29d3c96c5f
institution Directory Open Access Journal
issn 2165-5979
2165-5987
language English
last_indexed 2024-04-11T20:39:50Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Bioengineered
spelling doaj.art-623b0522f5264bd8ba12ea29d3c96c5f2022-12-22T04:04:14ZengTaylor & Francis GroupBioengineered2165-59792165-59872021-01-0112144044910.1080/21655979.2021.18718171871817MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4Li Cai0Lu Ye1Xiaoqing Hu2Wenfeng He3Debao Zhuang4Qi Guo5Kuanyong Shu6Youkun Jie7Jiangxi Maternal and Child Health HospitalJiangxi Maternal and Child Health HospitalJiangxi Maternal and Child Health HospitalThe Second Affiliated Hospital of Nanchang UniversityJiangxi Maternal and Child Health HospitalJiangxi Maternal and Child Health HospitalJiangxi Maternal and Child Health HospitalJiangxi Maternal and Child Health HospitalPrevious studies reported that miR-330-3p was involved in the progression of several cancers, but the potential roles of miR-330-3p in ovarian cancer (OC) were unclear. In the current study, we aimed to explore the expression pattern and functions of miR-330-3p in OC. The expression level of miR-330-3p in OC tissues and cell lines was detected using RT-qPCR. The proliferation, migration and invasion of OC cells were detected using CCK-8 assay and transwell assay, respectively. Bioinformatics analysis and luciferase reporter assay were used to analyze the targeted binding site of miR-330-3p and RIPK4. The results showed that miR-330-3p was significantly downregulated in OC tissues and cell lines. Overexpression of miR-330-3p inhibited the proliferation, migration and invasion of OC cells. Mechanistically, a dual-luciferase reported assay showed that RIPK4 is a target gene of miR-330-3p. Furthermore, rescue experiments revealed that miR-330-3p suppressed the proliferation, migration and invasion of OC cells by targeting RIPK4. In summary, our findings indicated that miR-330-3p suppressed the progression of OC by targeting RIPK4. Our results indicated that miR-330-3p/RIPK4 axis might act as a novel therapeutic target for OC treatment.http://dx.doi.org/10.1080/21655979.2021.1871817mir-330-3pripk4ovarian cancer
spellingShingle Li Cai
Lu Ye
Xiaoqing Hu
Wenfeng He
Debao Zhuang
Qi Guo
Kuanyong Shu
Youkun Jie
MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
Bioengineered
mir-330-3p
ripk4
ovarian cancer
title MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
title_full MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
title_fullStr MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
title_full_unstemmed MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
title_short MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
title_sort microrna mir 330 3p suppresses the progression of ovarian cancer by targeting ripk4
topic mir-330-3p
ripk4
ovarian cancer
url http://dx.doi.org/10.1080/21655979.2021.1871817
work_keys_str_mv AT licai micrornamir3303psuppressestheprogressionofovariancancerbytargetingripk4
AT luye micrornamir3303psuppressestheprogressionofovariancancerbytargetingripk4
AT xiaoqinghu micrornamir3303psuppressestheprogressionofovariancancerbytargetingripk4
AT wenfenghe micrornamir3303psuppressestheprogressionofovariancancerbytargetingripk4
AT debaozhuang micrornamir3303psuppressestheprogressionofovariancancerbytargetingripk4
AT qiguo micrornamir3303psuppressestheprogressionofovariancancerbytargetingripk4
AT kuanyongshu micrornamir3303psuppressestheprogressionofovariancancerbytargetingripk4
AT youkunjie micrornamir3303psuppressestheprogressionofovariancancerbytargetingripk4